Stock IKT INHIBIKASE THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Chart Inhibikase Therapeutics, Inc.

Equities

IKT

US45719W2052

Delayed Nasdaq
Other stock markets
 10:52:51 2024-06-14 am EDT 		5-day change 1st Jan Change
1.5 USD -1.96% Intraday chart for Inhibikase Therapeutics, Inc. -11.24% +18.11%
Jun. 05 Inhibikase Therapeutics, Inc. Announces Expansion to Its Therapeutic Pipeline CI
May. 21 HC Wainwright Adjusts Inhibikase Therapeutics Price Target to $23 From $27, Maintains Buy Rating MT
7c.IbB2YX23t5_KR2ANfl5d4O3sU021mNnHyEopaPMalpM.cNc-NUTVgdi4BihHSxE0tNrUBQfb37XzsgN-B7AorvZm_jISKsCHrJs9IQ~4bed5393c1d39b01dbb630430919f030
  1. Stock Market
  2. Equities
  3. IKT Stock
  4. Charts Inhibikase Therapeutics, Inc.
  5. News Chart